Your browser doesn't support javascript.
loading
Enhanced Surveillance for Histoplasmosis-9 States, 2018-2019.
Benedict, Kaitlin; McCracken, Stephanie; Signs, Kimberly; Ireland, Malia; Amburgey, Victoria; Serrano, Jose Antonio; Christophe, Natalie; Gibbons-Burgener, Suzanne; Hallyburton, Sara; Warren, Kimberly A; Keyser Metobo, Alison; Odom, Racheal; Groenewold, Matthew R; Jackson, Brendan R.
Afiliação
  • Benedict K; Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • McCracken S; Michigan Department of Health and Human Services, Lansing, Michigan, USA.
  • Signs K; Michigan Department of Health and Human Services, Lansing, Michigan, USA.
  • Ireland M; Minnesota Department of Health, St. Paul, Minnesota, USA.
  • Amburgey V; Kentucky Department for Public Health, Frankfort, Kentucky, USA.
  • Serrano JA; Louisiana Department of Health, Baton Rouge, Louisiana, USA.
  • Christophe N; Louisiana Department of Health, Baton Rouge, Louisiana, USA.
  • Gibbons-Burgener S; Wisconsin Department of Health Services, Madison, Wisconsin, USA.
  • Hallyburton S; Indiana State Department of Health, Indianapolis, Indiana, USA.
  • Warren KA; Pennsylvania Department of Health, Wilkes-Barre, Pennsylvania, USA.
  • Keyser Metobo A; Nebraska Department of Health and Human Services, Lincoln, Nebraska, USA.
  • Odom R; Arkansas Department of Health, Little Rock, Arkansas, USA.
  • Groenewold MR; National Institute for Occupational Safety and Health, Cincinnati Ohio, USA.
  • Jackson BR; Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Open Forum Infect Dis ; 7(9): ofaa343, 2020 Sep.
Article em En | MEDLINE | ID: mdl-32964064
ABSTRACT

BACKGROUND:

Histoplasmosis is often described as the most common endemic mycosis in the United States, but much remains unknown about its epidemiology among the general population.

METHODS:

We conducted enhanced surveillance in 9 states during 2018-2019 by identifying cases through routine surveillance and interviewing 301 patients about their clinical features and exposures.

RESULTS:

Before being tested for histoplasmosis, 60% saw a health care provider ≥3 times, and 53% received antibacterial medication. The median time from seeking health care to diagnosis (range) was 23 (0-269) days. Forty-nine percent were hospitalized, and 69% said that histoplasmosis interfered with their daily activities (median [range], 56 [2-3960] days). Possible exposures included handling plants (48%) and bird or bat droppings (24%); 22% reported no specific exposures. Only 15% had heard of histoplasmosis before their illness.

CONCLUSIONS:

Histoplasmosis can be severe and prolonged. Additional educational efforts to increase public and provider awareness and reduce delays in diagnosis are needed.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos